First human test of new drug ARC-520 begins
NCT ID NCT01872065
Summary
This early-stage study tested the safety and how the body processes ARC-520 in healthy adults. Researchers gave increasing doses to 54 volunteers to check for side effects and measure drug levels in the blood. The goal was to gather basic safety information before testing in patients with specific diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.